{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T23:43:16Z","timestamp":1783813396910,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 104-2314-B-010-051 MY3"],"award-info":[{"award-number":["MOST 104-2314-B-010-051 MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taichung Veterans General Hospital, Taiwan","award":["TCVGH-1066802C"],"award-info":[{"award-number":["TCVGH-1066802C"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The coexistence of inflammatory bowel disease (IBD) and bullous pemphigoid (BP) has been reported. No large-scale study to date has explored the relationship between these diseases. This population-based case-control study examined the association between IBD and BP by using a nationwide database. A total of 5,263 BP patients and 21,052 age- and gender-, hospital visit number-matched controls were identified in the National Health Insurance Research Database of Taiwan (1997\u20132013). Demographic characteristics and comorbidities including IBD were compared. Logistic regression was conducted to examine the predicting factors for BP. The mean age at diagnosis was 74.88\u00a0years and 54.3% of subjects were male. BP patients tended to have more cardiovascular risk factors, autoimmune and neurologic comorbidities, and hematologic cancers than matched controls. There were 20 cases of IBD (0.38%), mostly ulcerative colitis (N\u2009=\u200917, 0.32%) among BP patients, compared to 33 IBD cases (0.16%) among controls (p\u2009&lt;\u20090.001). Ulcerative colitis was found to be significantly associated with BP [adjusted odds ratio (OR) 3.60, 95% confidence interval (CI) 1.91\u20136.77, p\u2009&lt;\u20090.001] on multivariate analysis. Treatment for IBD was not associated with BP development. Information about diet, lifestyle, alcohol consumption, and smoking habit was not available. We concluded that\u00a0UC is independently associated with BP.<\/jats:p>","DOI":"10.1038\/s41598-020-69475-0","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T10:04:12Z","timestamp":1596017052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Association between inflammatory bowel disease and bullous pemphigoid: a population-based case\u2013control study"],"prefix":"10.1038","volume":"10","author":[{"given":"Yi-Ju","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Kuei","family":"Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Ting","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu J.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Ching","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"key":"69475_CR1","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.3389\/fimmu.2019.01506","volume":"10","author":"G Genovese","year":"2019","unstructured":"Genovese, G. et al. New insights into the pathogenesis of bullous pemphigoid: 2019 update. Front. Immunol. 10, 1506. https:\/\/doi.org\/10.3389\/fimmu.2019.01506 (2019).","journal-title":"Front. Immunol."},{"key":"69475_CR2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fmed.2018.00220","volume":"5","author":"K Kridin","year":"2018","unstructured":"Kridin, K. & Ludwig, R. J. The growing incidence of bullous pemphigoid: overview and potential explanations. Front. Med. 5, 220. https:\/\/doi.org\/10.3389\/fmed.2018.00220 (2018).","journal-title":"Front. Med."},{"key":"69475_CR3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1365-2133.2011.10386.x","volume":"165","author":"YJ Chen","year":"2011","unstructured":"Chen, Y. J. et al. Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study. Br. J. Dermatol. 165, 593\u2013599 (2011).","journal-title":"Br. J. Dermatol."},{"key":"69475_CR4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fmed.2018.00238","volume":"5","author":"R Bech","year":"2018","unstructured":"Bech, R., Kibsgaard, L. & Vestergaard, C. Comorbidities and treatment strategies in bullous pemphigoid: an appraisal of the existing literature. Front. Med. 5, 238. https:\/\/doi.org\/10.3389\/fmed.2018.00238 (2018).","journal-title":"Front. Med."},{"key":"69475_CR5","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1111\/bjd.15405","volume":"176","author":"L Kibsgaard","year":"2017","unstructured":"Kibsgaard, L. et al. Increased frequency of multiple sclerosis among patients with bullous pemphigoid: a population-based cohort study on comorbidities anchored around the diagnosis of bullous pemphigoid. Br. J. Dermatol. 176, 1486\u20131491 (2017).","journal-title":"Br. J. Dermatol."},{"key":"69475_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2340\/00015555-1925","volume":"95","author":"L Kibsgaard","year":"2015","unstructured":"Kibsgaard, L., Bay, B., Deleuran, M. & Vestergaard, C. A retrospective consecutive case-series study on the effect of systemic treatment, length of admission time, and co-morbidities in 98 bullous pemphigoid patients admitted to a tertiary centre. Acta. Derm. Venereol. 95, 307\u2013311 (2015).","journal-title":"Acta. Derm. Venereol."},{"key":"69475_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/bjd.14821","volume":"176","author":"Z Ren","year":"2017","unstructured":"Ren, Z. et al. Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the USA. Br. J. Dermatol. 176, 87\u201399 (2017).","journal-title":"Br. J. Dermatol."},{"key":"69475_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.semcdb.2017.07.016","volume":"69","author":"M Horie","year":"2017","unstructured":"Horie, M., Yoshioka, N. & Takebayashi, H. BPAG1 in muscles: Structure and function in skeletal, cardiac and smooth muscle. Semin. Cell. Dev. Biol. 69, 26\u201333 (2017).","journal-title":"Semin. Cell. Dev. Biol."},{"key":"69475_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.5217\/ir.2018.16.2.194","volume":"16","author":"S Kedia","year":"2018","unstructured":"Kedia, S., Limdi, J. K. & Ahuja, V. Management of inflammatory bowel disease in older persons: evolving paradigms. Intest. Res. 16, 194\u2013208 (2018).","journal-title":"Intest. Res."},{"key":"69475_CR10","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/ecco-jcc\/jjv193","volume":"10","author":"JC Wilson","year":"2016","unstructured":"Wilson, J. C., Furlano, R. I., Jick, S. S. & Meier, C. R. Inflammatory bowel disease and the risk of autoimmune diseases. J. Crohn\u2019s. Colitis. 10, 186\u2013193 (2016).","journal-title":"J. Crohn's. Colitis."},{"key":"69475_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","volume":"142","author":"NA Molodecky","year":"2012","unstructured":"Molodecky, N. A. et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142, 46\u201354 (2012).","journal-title":"Gastroenterology"},{"key":"69475_CR12","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2018","unstructured":"Ng, S. C. et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390, 2769\u20132778 (2018).","journal-title":"Lancet"},{"key":"69475_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.5217\/ir.2018.00096","volume":"17","author":"HH Yen","year":"2019","unstructured":"Yen, H. H. et al. Epidermiological trend of inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide population based study. Intest. Res. 17, 54\u201362 (2019).","journal-title":"Intest. Res."},{"key":"69475_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00281-014-0454-4","volume":"37","author":"K Matsuoka","year":"2015","unstructured":"Matsuoka, K. & Kanai, T. The gut microbiota and inflammatory bowel disease. Semin. Immunopathol. 37, 47\u201355 (2015).","journal-title":"Semin. Immunopathol."},{"key":"69475_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1365-2230.2012.04383.x","volume":"37","author":"AR Shipman","year":"2012","unstructured":"Shipman, A. R., Reddy, H. & Wojnarowska, F. Association between the subepidermal autoimmune blistering diseases linear IgA disease and the pemphigoid group and inflammatory bowel disease: two case reports and literature review. Clin. Exp. Dermatol. 37, 461\u2013468 (2012).","journal-title":"Clin. Exp. Dermatol."},{"key":"69475_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000489163","volume":"10","author":"S Hoffmann","year":"2018","unstructured":"Hoffmann, S., Berneburg, M. & Schreml, S. Bullous pemphigoid associated with adalimumab therapy in a patient with ulcerative colitis. Case. Rep. Dermatol. 10, 145\u2013148 (2018).","journal-title":"Case. Rep. Dermatol."},{"key":"69475_CR17","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1007\/s10620-004-9567-2","volume":"49","author":"L Selby","year":"2004","unstructured":"Selby, L., De Castro, F. & De Villiers, W. J. The association of bullous pemphigoid and ulcerative colitis. Dig. Dis. Sci. 49, 1768\u20131770 (2004).","journal-title":"Dig. Dis. Sci."},{"key":"69475_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000051745","volume":"203","author":"M Vaccaro","year":"2001","unstructured":"Vaccaro, M., D\u2019Amico, D., Borgia, F., Guarneri, F. & Cannavo, S. Bullous pemphigoid following use of sulphasalazine for ulcerative colitis: drug-induced eruption or true association?. Dermatology 203, 194\u2013195 (2001).","journal-title":"Dermatology"},{"key":"69475_CR19","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2133.1996.tb16257.x","volume":"134","author":"PV Harrison","year":"1996","unstructured":"Harrison, P. V. et al. Bullous pemphigoid and ulcerative colitis: a report of two cases and description of immunoblot findings. Br. J. Dermatol. 134, 599\u2013600 (1996).","journal-title":"Br. J. Dermatol."},{"issue":"2 Pt 1","key":"69475_CR20","first-page":"303","volume":"19","author":"JH Barth","year":"1998","unstructured":"Barth, J. H. et al. Pemphigoid and ulcerative colitis. J. Am. Acad. Dermatol. 19(2 Pt 1), 303\u2013308 (1998).","journal-title":"J. Am. Acad. Dermatol."},{"key":"69475_CR21","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/j.1365-4362.1982.tb02042.x","volume":"21","author":"AR Ahmed","year":"1982","unstructured":"Ahmed, A. R., Kaplan, R. P., Hardy, D., Feldman, E. & Pitt, H. Bullous pemphigoid and ulcerative colitis. Int. J. Dermatol. 21, 594\u2013598 (1982).","journal-title":"Int. J. Dermatol."},{"key":"69475_CR22","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jaad.2019.07.029","volume":"82","author":"S Narla","year":"2020","unstructured":"Narla, S. & Silverberg, J. I. Associations of pemphigus or pemphigoid with autoimmune disorders in US adult inpatients. J. Am. Acad. Dermatol. 82, 586\u2013595 (2020).","journal-title":"J. Am. Acad. Dermatol."},{"key":"69475_CR23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/pds.2087","volume":"20","author":"CL Cheng","year":"2011","unstructured":"Cheng, C. L., Kao, Y. H., Lin, S. J., Lee, C. H. & Lai, M. L. Validation of the national health insurance research database with ischemic stroke cases in Taiwan. Pharmacoepidemiol. Drug. saf. 20, 236\u2013242 (2011).","journal-title":"Pharmacoepidemiol. Drug. saf."},{"key":"69475_CR24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jfma.2013.09.009","volume":"114","author":"CY Hsieh","year":"2015","unstructured":"Hsieh, C. Y., Chen, C. H., Li, C. Y. & Lai, M. L. Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database. J. Formos. Med. Assoc. 114, 254\u2013259 (2015).","journal-title":"J. Formos. Med. Assoc."},{"key":"69475_CR25","first-page":"157","volume":"104","author":"CC Lin","year":"2005","unstructured":"Lin, C. C., Lai, M. S., Syu, C. Y., Chang, S. C. & Tseng, F. Y. Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. J. Formos. Med. Assoc. 104, 157\u2013163 (2005).","journal-title":"J. Formos. Med. Assoc."},{"key":"69475_CR26","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1001\/2012.jama.11975","volume":"308","author":"CY Wu","year":"2012","unstructured":"Wu, C. Y. et al. Association between nucleoside analogs and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection. JAMA 308, 1906\u20131914 (2012).","journal-title":"JAMA"},{"key":"69475_CR27","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jaad.2016.11.065","volume":"76","author":"CY Wu","year":"2017","unstructured":"Wu, C. Y. et al. Risk of inflammatory bowel disease in patients with rosacea: results from a nationwide cohort study in Taiwan. J. Am. Acad. Dermatol. 76, 911\u2013917 (2017).","journal-title":"J. Am. Acad. Dermatol."},{"key":"69475_CR28","doi-asserted-by":"publisher","first-page":"e2018062","DOI":"10.4178\/epih.e2018062","volume":"40","author":"LY Lin","year":"2018","unstructured":"Lin, L. Y., Warren-Gash, C., Smeeth, L. & Chen, P. C. Data resource profile: the National Health Insurance Research Database (NHIRD). Epidemiol. Health. 40, e2018062 (2018).","journal-title":"Epidemiol. Health."},{"key":"69475_CR29","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/(SICI)1097-4644(19990301)72:3<356::AID-JCB5>3.0.CO;2-M","volume":"72","author":"S Aho","year":"1999","unstructured":"Aho, S. & Uitto, J. 180-kD bullous pemphigoid antigen\/type XVII collagen: tissue-specific expression and molecular interactions with keratin 18. J. Cell. Biochem. 72, 356\u2013367 (1999).","journal-title":"J. Cell. Biochem."},{"key":"69475_CR30","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1083\/jcb.200012098","volume":"154","author":"CL Leung","year":"2001","unstructured":"Leung, C. L., Zheng, M., Prater, S. M. & Liem, R. K. The BPAG1 locus: Alternative splicing produces multiple isoforms with distinct cytoskeletal linker domains, including predominant isoforms in neurons and muscles. J. Cell. Biol. 154, 691\u2013697 (2001).","journal-title":"J. Cell. Biol."},{"key":"69475_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41575-018-0084-8","volume":"16","author":"AR Moschen","year":"2019","unstructured":"Moschen, A. R., Tilg, H. & Raine, T. IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting. Nat. Rev. Gastroenterol. Hepatol. 16, 185\u2013196 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"69475_CR32","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.3389\/fmicb.2018.02247","volume":"9","author":"T Zuo","year":"2018","unstructured":"Zuo, T. & Ng, S. C. The Gut microbiota in the pathogenesis and therapeutics of inflammatory bowel disease. Front. Microbiol. 9, 2247. https:\/\/doi.org\/10.3389\/fmicb.2018.02247 (2018).","journal-title":"Front. Microbiol."},{"key":"69475_CR33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.clim.2018.09.001","volume":"197","author":"S Dragasevic","year":"2018","unstructured":"Dragasevic, S. et al. Importance of TLR9-IL23-IL17 axis in inflammatory bowel disease development: gene expression profiling study. Clin. Immunol. 197, 86\u201395 (2018).","journal-title":"Clin. Immunol."},{"key":"69475_CR34","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/ecco-jcc\/jjz152","volume":"14","author":"F Alinaghi","year":"2020","unstructured":"Alinaghi, F. et al. Global prevalence and bidirectional association between psoriasis and inflammatory bowel disease: a systematic review and meta-analysis. J. Crohn\u2019s. Colitis. 14, 351\u2013360 (2020).","journal-title":"J. Crohn's. Colitis."},{"key":"69475_CR35","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1111\/j.1600-0625.2011.01378.x","volume":"20","author":"M Arakawa","year":"2011","unstructured":"Arakawa, M. et al. Lesional Th17 cells and regulatory T cells in bullous pemphigoid. Exp. Dermatol. 20, 1022\u20131024 (2011).","journal-title":"Exp. Dermatol."},{"key":"69475_CR36","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaut.2018.09.003","volume":"96","author":"L Chakievska","year":"2019","unstructured":"Chakievska, L. et al. IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid. J. Autoimmun. 96, 104\u2013112 (2019).","journal-title":"J. Autoimmun."},{"key":"69475_CR37","doi-asserted-by":"crossref","unstructured":"Zebrowska, A., et al. IL-17 expression in dermatitis herpetiformis and bullous pemphigoid. Mediators. Inflamm. 2013, 967987; 10.1155\/2013\/967987 (2013).","DOI":"10.1155\/2013\/967987"},{"key":"69475_CR38","doi-asserted-by":"crossref","unstructured":"Plee, J., et al. Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome. Sci Rep. 5, 18001; 10.1038\/srep18001 (2015).","DOI":"10.1038\/srep18001"},{"key":"69475_CR39","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1001\/jamadermatol.2018.3631","volume":"154","author":"Y Fu","year":"2018","unstructured":"Fu, Y., Lee, C. H. & Chi, C. C. Association of psoriasis with inflammatory bowel disease: a systemic review and meta-analysis. JAMA. Dermatol. 154, 1417\u20131423 (2018).","journal-title":"JAMA. Dermatol."},{"key":"69475_CR40","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1365-2133.2011.10386.x","volume":"165","author":"YJ Chen","year":"2011","unstructured":"Chen, Y. J. et al. Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study. Br. J. Dermaol. 165, 593\u2013599 (2011).","journal-title":"Br. J. Dermaol."},{"key":"69475_CR41","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/jdv.12366","volume":"28","author":"PG Stavropoulos","year":"2014","unstructured":"Stavropoulos, P. G., Soura, E. & Antoniou, C. Drug-induced pemphigoid: a review of the literature. J. Eur. Acad. Dermatol. Venereol. 28, 1133\u20131140 (2014).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"69475_CR42","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1001\/archderm.141.11.1474-b","volume":"141","author":"LK Ferris","year":"2005","unstructured":"Ferris, L. K., Jukic, D., English, J. C. 3rd. & Zirwas, M. J. Drug-induced bullous pemphigoid caused by a generic Canadian medication obtained over the internet. Arch. Dermatol. 141, 1474\u20131476 (2005).","journal-title":"Arch. Dermatol."},{"key":"69475_CR43","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/MEG.0000000000001140","volume":"30","author":"K Kridin","year":"2018","unstructured":"Kridin, K., Comaneshter, D. & Cohen, A. D. Short article: Crohn\u2019s disease and pemphigus: is there an association? A population-based study. Eur. J. Gastroenterol. Hepatol. 30, 727\u2013729 (2018).","journal-title":"Eur. J. Gastroenterol. Hepatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69475-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69475-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69475-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T15:20:31Z","timestamp":1670340031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69475-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["69475"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-69475-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,29]]},"assertion":[{"value":"12 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12727"}}